Covance 4Q09 4Q Revenues: $485.1 million (+11%) 4Q Earnings: $41.5 million (-9%) FY Revenues: $1.9 billion (+8%) FY Earnings: $175.9 million (-11%) Comments: Early Development revenues were down 5% to $203.1 million in 4Q09 and down 6% to $844.8 million in FY09, due to reduced demand. Toxicologu revenues were up for the second consecutive quarter, but Covance did not provide numbers for that subsegment. Late-Stage Development revenues were up 26% to $281.9 million in 4Q09 and up 2...